vs

Side-by-side financial comparison of BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

BRIGHT HORIZONS FAMILY SOLUTIONS INC. is the larger business by last-quarter revenue ($733.7M vs $397.6M, roughly 1.8× Guardian Pharmacy Services, Inc.).

Bright Horizons Family Solutions Inc. is a United States–based child-care provider and is the largest provider of employer-sponsored child care. It also provides back-up child care and elder care, tuition program management, education advising, and student loan repayment programs. It is headquartered in Newton, Massachusetts.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

BFAM vs GRDN — Head-to-Head

Bigger by revenue
BFAM
BFAM
1.8× larger
BFAM
$733.7M
$397.6M
GRDN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BFAM
BFAM
GRDN
GRDN
Revenue
$733.7M
$397.6M
Net Profit
$20.9M
Gross Margin
19.3%
21.5%
Operating Margin
6.2%
7.7%
Net Margin
5.3%
Revenue YoY
8.8%
Net Profit YoY
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFAM
BFAM
GRDN
GRDN
Q4 25
$733.7M
$397.6M
Q3 25
$802.8M
$377.4M
Q2 25
$731.6M
$344.3M
Q1 25
$665.5M
$329.3M
Q4 24
$674.1M
Q3 24
$719.1M
$314.4M
Q2 24
$670.1M
Q1 24
$622.7M
Net Profit
BFAM
BFAM
GRDN
GRDN
Q4 25
$20.9M
Q3 25
$78.6M
$9.8M
Q2 25
$54.8M
$9.0M
Q1 25
$38.0M
$9.4M
Q4 24
Q3 24
$54.9M
$-122.0M
Q2 24
$39.2M
Q1 24
$17.0M
Gross Margin
BFAM
BFAM
GRDN
GRDN
Q4 25
19.3%
21.5%
Q3 25
27.0%
19.8%
Q2 25
25.0%
19.8%
Q1 25
23.4%
19.5%
Q4 24
20.8%
Q3 24
25.2%
19.4%
Q2 24
24.2%
Q1 24
21.7%
Operating Margin
BFAM
BFAM
GRDN
GRDN
Q4 25
6.2%
7.7%
Q3 25
15.1%
4.3%
Q2 25
11.8%
3.7%
Q1 25
9.4%
3.9%
Q4 24
7.2%
Q3 24
12.4%
-33.3%
Q2 24
10.3%
Q1 24
6.4%
Net Margin
BFAM
BFAM
GRDN
GRDN
Q4 25
5.3%
Q3 25
9.8%
2.6%
Q2 25
7.5%
2.6%
Q1 25
5.7%
2.9%
Q4 24
Q3 24
7.6%
-38.8%
Q2 24
5.8%
Q1 24
2.7%
EPS (diluted)
BFAM
BFAM
GRDN
GRDN
Q4 25
$0.38
Q3 25
$1.37
Q2 25
$0.95
Q1 25
$0.66
Q4 24
$0.50
Q3 24
$0.94
Q2 24
$0.67
Q1 24
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFAM
BFAM
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$140.1M
$65.6M
Total DebtLower is stronger
$747.6M
$0
Stockholders' EquityBook value
$1.3B
$217.9M
Total Assets
$3.9B
$412.7M
Debt / EquityLower = less leverage
0.56×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFAM
BFAM
GRDN
GRDN
Q4 25
$140.1M
$65.6M
Q3 25
$116.6M
$36.5M
Q2 25
$179.2M
$18.8M
Q1 25
$112.0M
$14.0M
Q4 24
$110.3M
Q3 24
$109.9M
$37.2M
Q2 24
$140.2M
Q1 24
$63.7M
Total Debt
BFAM
BFAM
GRDN
GRDN
Q4 25
$747.6M
$0
Q3 25
$747.5M
Q2 25
$797.0M
Q1 25
$872.7M
Q4 24
$918.4M
Q3 24
$925.7M
$34.3M
Q2 24
$931.9M
Q1 24
$938.1M
Stockholders' Equity
BFAM
BFAM
GRDN
GRDN
Q4 25
$1.3B
$217.9M
Q3 25
$1.4B
$195.5M
Q2 25
$1.4B
$179.7M
Q1 25
$1.3B
$163.2M
Q4 24
$1.3B
Q3 24
$1.4B
$133.9M
Q2 24
$1.3B
Q1 24
$1.2B
Total Assets
BFAM
BFAM
GRDN
GRDN
Q4 25
$3.9B
$412.7M
Q3 25
$3.9B
$390.0M
Q2 25
$3.9B
$356.3M
Q1 25
$3.8B
$334.0M
Q4 24
$3.9B
Q3 24
$3.9B
$348.0M
Q2 24
$3.8B
Q1 24
$3.8B
Debt / Equity
BFAM
BFAM
GRDN
GRDN
Q4 25
0.56×
0.00×
Q3 25
0.52×
Q2 25
0.57×
Q1 25
0.66×
Q4 24
0.72×
Q3 24
0.66×
0.26×
Q2 24
0.73×
Q1 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFAM
BFAM
GRDN
GRDN
Operating Cash FlowLast quarter
$350.7M
$34.6M
Free Cash FlowOCF − Capex
$258.5M
FCF MarginFCF / Revenue
35.2%
Capex IntensityCapex / Revenue
12.6%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$402.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFAM
BFAM
GRDN
GRDN
Q4 25
$350.7M
$34.6M
Q3 25
$-17.6M
$28.2M
Q2 25
$134.2M
$19.9M
Q1 25
$86.2M
$17.6M
Q4 24
$337.5M
Q3 24
$-8.9M
Q2 24
$109.4M
Q1 24
$116.3M
Free Cash Flow
BFAM
BFAM
GRDN
GRDN
Q4 25
$258.5M
Q3 25
$-42.4M
$24.2M
Q2 25
$115.4M
Q1 25
$70.9M
Q4 24
$240.2M
Q3 24
$-32.2M
Q2 24
$86.8M
Q1 24
$96.9M
FCF Margin
BFAM
BFAM
GRDN
GRDN
Q4 25
35.2%
Q3 25
-5.3%
6.4%
Q2 25
15.8%
Q1 25
10.7%
Q4 24
35.6%
Q3 24
-4.5%
Q2 24
13.0%
Q1 24
15.6%
Capex Intensity
BFAM
BFAM
GRDN
GRDN
Q4 25
12.6%
Q3 25
3.1%
1.1%
Q2 25
2.6%
Q1 25
2.3%
Q4 24
14.4%
Q3 24
3.2%
Q2 24
3.4%
Q1 24
3.1%
Cash Conversion
BFAM
BFAM
GRDN
GRDN
Q4 25
1.65×
Q3 25
-0.22×
2.87×
Q2 25
2.45×
2.21×
Q1 25
2.26×
1.86×
Q4 24
Q3 24
-0.16×
Q2 24
2.79×
Q1 24
6.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons